Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00616317 · ClinicalTrials.gov registry record
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
A clinical trial of Antiphospholipid Syndrome, sponsored by University of California, Davis.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT00616317: Recruiting study of Antiphospholipid Syndrome, sponsored by University of California, Davis.
NCT00616317 is a study of Antiphospholipid Syndrome that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 50 participants, below the 1,442-participant average among 6 other Antiphospholipid Syndrome trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00616317, a study of Antiphospholipid Syndrome, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.
Conditions Studied
Study Locations (1)
California
- UC Davis Medical Center - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2006-09 |
| Est. Completion | 2040-01 |
What NCT00616317 shows while recruiting
NCT00616317 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,442-participant average among 6 other Antiphospholipid Syndrome trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Antiphospholipid Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT00616317 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00616317 about?
NCT00616317 is a clinical study titled "Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study". The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.
What is the current status of trial NCT00616317?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2006-09. Estimated completion is 2040-01.
What conditions does trial NCT00616317 study?
This clinical trial studies the following conditions: Antiphospholipid Syndrome.
Who is sponsoring clinical trial NCT00616317?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00616317 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Antiphospholipid Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Rheumatology Patient Registry and Biorepository
RECRUITING
-
Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
RECRUITING
-
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
RECRUITING
-
Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients
COMPLETED · Phase 2
-
Reliability of Point-of-care INR Measurements in Patients With Antiphospholipid-antibody Syndrome Treated With Warfarin
COMPLETED
-
Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia